You are here

Responses

Article menu
Download PDFPDF
Editorial
Hypoxia-inducible factors: new strategies for treatment of obesity-induced metabolic diseases
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 6 May 2022
    HIF isoforms and personlized anti-obesity strategies ?
    • Farwa Munir, Doctor of Nutrition Faculty of Medicine, Universiti Sultan Zainal Abidin
    • Other Contributors:
      • Atif Baig, Molecular Geneticist

    Dear Editor,

    We have read the respective article entitled “overview of the possible treatment of hypoxia-induced obesity” by Sung Sik Choe and Jae Bum Kim(1). We were pleased to see how concisely they have linked hypoxia and hypoxia inducible factors with obesity. We agree to their problem statement, the gap analysis and the qualitative narrative review they have done to explain the process of inflammatory obesity.
    Hypoxia is defined as a state in which the tissue oxygen levels are less than normal. The range of normal oxygen levels in tissue is 3% to 9% (2). A stable transcription factor is activated in a hypoxic state, known as the Hypoxia-inducible factor (HIF). Hypoxia inducible factor has a greater role in stabilizing oxygen levels by increasing circulating hemoglobin (3). It is a heterodimeric transcription factor as per its structure, further divided into alpha and beta subunits. In inflammatory induced obesity, the alpha subunit is found to have a prominent role. Hypoxia-inducible factor a is further divided into two units, HIF 1a and HIF 2a (4). These two units play an antagonistic role. HIF 1a plays a significant role in increasing inflammation in adipose tissues leading to an increase in the risk of inflammatory obesity. As per the location of the HIF 1A gene, it is mapped and located on human chromosome 14q21-24. It codes for the transcription factor HIF 1a, an essential factor for systemic oxygen homeostasis. Higher HIF 1a can indicate squamous ce...

    Show More
    Conflict of Interest:
    None declared.